BGC > Produktsuche > Tetrabenazine

Molecular Formula: C19H27NO3
Molecular Weight: 317.42258

Description:
Tetrabenazine is a VMAT inhibitor used for the treatment of hyperkinetic movement disorder. It is a monoamine-depleting and dopamine-receptor-blocking drug, and is an effective and safe drug for the treatment of a variety of hyperkinetic movement disorders.

• Molecular Weight:317.42
• Boiling Point:448.9±45.0 °C (Predicted)
• Melting Point:125 °C
• Purity:>98%

Molecular Formula:
C19H27NO3
Canonical SMILES:
O=C1CC2C3=CC(OC)=C(OC)C=C3CCN2CC1CC(C)C
InChI:
InChI=1/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3/t14-,16-/s2
InChIKey:
MKJIEFSOBYUXJB-VTLFJGNJNA-N
Solubility:
Soluble in Chloroform (Slightly), Methanol (Slightly)
Appearance:
White to Off-white Solid
Storage: Store at 2-8°C
Synonyms:
2H-Benzo[a]quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-, (3R,11bR)-rel-; 2H-Benzo[a]quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; 2H-Benzo[a]quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-, cis-; (±)-Tetrabenazine; cis-2-Oxo-3-isobutyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11bH-benzo[a]quinolizine; NSC 169886; NSC 172187; Ro 1-9569; Rubigen; Xenazine